| |
| |
|
| Insider
Information: |
Kaldor Stephen W |
| Relationship: |
|
| City: |
Morrisville |
| State: |
NC |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
1,615,826 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
1,615,826 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Furiex Pharmaceuticals, Inc. |
FURX |
Director |
2014-07-02 |
0 |
2013-03-11 |
0 |
Premium* |
|
|
Kinnate Biopharma Inc. |
KNTE |
|
2020-12-02 |
1,615,826 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
13 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| KNTE |
Kinnate Biopharma Inc. |
|
– • – |
2020-12-02 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,615,826 |
|
- |
|
| FURX |
Furiex Pharmaceuticals, I... |
Director |
• • – |
2014-07-02 |
4 |
D |
$0.00 |
$0 |
D/D |
(7,160) |
0 |
0 |
- |
|
| FURX |
Furiex Pharmaceuticals, I... |
Director |
• • – |
2014-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
3,580 |
7,160 |
0 |
- |
|
| FURX |
Furiex Pharmaceuticals, I... |
Director |
• • – |
2013-05-24 |
4 |
A |
$0.00 |
$0 |
D/D |
3,580 |
3,580 |
0 |
- |
|
| FURX |
Furiex Pharmaceuticals, I... |
Director |
– • – |
2013-03-13 |
4/A |
S |
$39.96 |
$65,854 |
D/D |
(1,648) |
0 |
0 |
- |
|
| FURX |
Furiex Pharmaceuticals, I... |
Director |
– • – |
2013-03-13 |
4/A |
OE |
$13.94 |
$22,973 |
D/D |
1,648 |
1,648 |
0 |
- |
|
| FURX |
Furiex Pharmaceuticals, I... |
Director |
– • – |
2013-03-12 |
4/A |
S |
$40.71 |
$39,611 |
D/D |
(973) |
0 |
0 |
- |
|
| FURX |
Furiex Pharmaceuticals, I... |
Director |
– • – |
2013-03-12 |
4/A |
OE |
$13.94 |
$13,564 |
D/D |
973 |
973 |
0 |
- |
|
| FURX |
Furiex Pharmaceuticals, I... |
Director |
– • – |
2013-03-12 |
4 |
S |
$40.71 |
$39,611 |
D/D |
(973) |
1,648 |
0 |
- |
|
| FURX |
Furiex Pharmaceuticals, I... |
Director |
– • – |
2013-03-11 |
4/A |
S |
$41.74 |
$224,519 |
D/D |
(5,379) |
0 |
0 |
- |
|
| FURX |
Furiex Pharmaceuticals, I... |
Director |
– • – |
2013-03-11 |
4/A |
OE |
$13.94 |
$74,983 |
D/D |
5,379 |
5,379 |
0 |
- |
|
| FURX |
Furiex Pharmaceuticals, I... |
Director |
– • – |
2013-03-11 |
4 |
S |
$41.74 |
$224,519 |
D/D |
(5,379) |
2,621 |
0 |
- |
|
| FURX |
Furiex Pharmaceuticals, I... |
Director |
– • – |
2013-03-11 |
4 |
OE |
$13.94 |
$111,520 |
D/D |
8,000 |
8,000 |
0 |
- |
|
13 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
